Can PROTACs truly become oral drugs?

Drug Discovery Today 2026

View at publisher

Authors: Anas Alhafi, Vivek Gupta

DOI: 10.1016/j.drudis.2026.104709

Cited by: 1

References: 50

Fields of Study & Subjects

Protein Degradation and Inhibitors HER2/EGFR in Cancer Research Receptor Mechanisms and Signaling

References 50